Tagged With Pharmaceutical

Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use

Young people are experiencing rare cases of heart inflammation after getting coronavirus vaccines, but doctors say the risk of COVID-19 is far greater

3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond

Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK

Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

The US just authorized Pfizer-BioNTech's coronavirus vaccine for teenagers, making it the first COVID-19 shot OK'd for 12- to 15-year-olds

Precipio extends 2-day gain to 404% following launch of the company's COVID-19 test on Amazon

Healthcare CEOs on how the pandemic is shaping the future of work

Getting AstraZeneca's shot is safer than flying on a plane, experts say - the bigger problem is an 'explosion of vaccine skepticism'

Pfizer's COVID-19 shot remains highly protective against the coronavirus, longer-term data shows

Vaccinex stock soars 223% on partnership deals using its antibody discovery platform

J&J just asked the US for emergency authorization of its COVID-19 vaccine, kicking off a process that could green-light its shot within weeks

J&J's single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection

Johnson & Johnson's CEO says crucial coronavirus vaccine data will come by early next week

6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.

Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorise the shot

The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot

Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic

French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline